23
Participants
Start Date
May 31, 2015
Primary Completion Date
November 30, 2017
Study Completion Date
January 31, 2018
HIZENTRA ®
Patients must fulfill inclusion criteria and remain stable at week 0, which means QMG does not increase by 3 points, will enter receive Hizentra for 12 weeks.
University at Buffalo, Buffalo
University of Kansas Medical Center, Kansas City
University of Texas Southwestern Medical Center, Dallas
Phoenix Neurological Associates, Phoenix
University of Toronto, Toronto
Collaborators (1)
CSL Behring
INDUSTRY
Mazen Dimachkie, MD
OTHER